JP2011530545A5 - - Google Patents

Download PDF

Info

Publication number
JP2011530545A5
JP2011530545A5 JP2011522392A JP2011522392A JP2011530545A5 JP 2011530545 A5 JP2011530545 A5 JP 2011530545A5 JP 2011522392 A JP2011522392 A JP 2011522392A JP 2011522392 A JP2011522392 A JP 2011522392A JP 2011530545 A5 JP2011530545 A5 JP 2011530545A5
Authority
JP
Japan
Prior art keywords
het
hal
atoms
coor
proportions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011522392A
Other languages
English (en)
Japanese (ja)
Other versions
JP5475778B2 (ja
JP2011530545A (ja
Filing date
Publication date
Priority claimed from DE102008037790A external-priority patent/DE102008037790A1/de
Application filed filed Critical
Publication of JP2011530545A publication Critical patent/JP2011530545A/ja
Publication of JP2011530545A5 publication Critical patent/JP2011530545A5/ja
Application granted granted Critical
Publication of JP5475778B2 publication Critical patent/JP5475778B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011522392A 2008-08-14 2009-07-16 腫瘍の治療のための二環式トリアゾール誘導体 Expired - Fee Related JP5475778B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102008037790A DE102008037790A1 (de) 2008-08-14 2008-08-14 Bicyclische Triazolderivate
DE102008037790.2 2008-08-14
PCT/EP2009/005172 WO2010017870A1 (de) 2008-08-14 2009-07-16 Bicyclische triazolderivate zur behandlung von tumoren

Publications (3)

Publication Number Publication Date
JP2011530545A JP2011530545A (ja) 2011-12-22
JP2011530545A5 true JP2011530545A5 (cg-RX-API-DMAC10.html) 2012-08-30
JP5475778B2 JP5475778B2 (ja) 2014-04-16

Family

ID=41138729

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011522392A Expired - Fee Related JP5475778B2 (ja) 2008-08-14 2009-07-16 腫瘍の治療のための二環式トリアゾール誘導体

Country Status (16)

Country Link
US (1) US8435986B2 (cg-RX-API-DMAC10.html)
EP (1) EP2310013B1 (cg-RX-API-DMAC10.html)
JP (1) JP5475778B2 (cg-RX-API-DMAC10.html)
KR (1) KR20110051243A (cg-RX-API-DMAC10.html)
CN (1) CN102123710B (cg-RX-API-DMAC10.html)
AR (1) AR073055A1 (cg-RX-API-DMAC10.html)
AU (1) AU2009281491B2 (cg-RX-API-DMAC10.html)
BR (1) BRPI0914555A2 (cg-RX-API-DMAC10.html)
CA (1) CA2733941C (cg-RX-API-DMAC10.html)
DE (1) DE102008037790A1 (cg-RX-API-DMAC10.html)
EA (1) EA201100334A1 (cg-RX-API-DMAC10.html)
ES (1) ES2648233T3 (cg-RX-API-DMAC10.html)
IL (1) IL211193A0 (cg-RX-API-DMAC10.html)
MX (1) MX2011001511A (cg-RX-API-DMAC10.html)
WO (1) WO2010017870A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA201101899B (cg-RX-API-DMAC10.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2717509A1 (en) * 2008-03-03 2009-09-11 Tiger Pharmatech Tyrosine kinase inhibitors
EA025466B1 (ru) 2009-12-31 2016-12-30 Хатчисон Медифарма Лимитед Определенные триазолопиридины и триазолопиразины, их композиции и способы их применения
NZ604306A (en) * 2010-05-17 2015-02-27 Incozen Therapeutics Pvt Ltd Novel 3,5-disubstitued-3h-imidazo[4,5-b]pyridine and 3,5- disubstitued -3h-[1,2,3]triazolo[4,5-b] pyridine compounds as modulators of protein kinases
US8575201B2 (en) * 2010-09-23 2013-11-05 Boehringer Ingelheim International Gmbh Oxadiazole inhibitors of leukotriene production
EP3053923B1 (en) * 2013-09-30 2018-04-11 Korea Research Institute of Chemical Technology Triazolopyrazine derivatives as tyrosin kinase inhibitors
US10227588B2 (en) * 2013-10-04 2019-03-12 Novartis Ag 3′end caps for RNAi agents for use in RNA interference
EP3052107B1 (en) 2013-10-04 2018-05-02 Novartis AG Organic compounds to treat hepatitis b virus
GB201321740D0 (en) * 2013-12-09 2014-01-22 Ucb Pharma Sa Therapeutic agents
WO2015103133A1 (en) * 2013-12-30 2015-07-09 Genentech, Inc. Serine/threonine kinase inhibitors
MY196648A (en) 2016-02-05 2023-04-27 Denali Therapeutics Inc Inhibitors of Receptor-Interacting Protein Kinase 1
CN110383066B (zh) 2016-12-09 2023-03-31 戴纳立制药公司 化合物、组合物和方法
KR20180092096A (ko) * 2017-02-08 2018-08-17 에이비온 주식회사 트리아졸로 피라진 유도체의 신규한 다형체 및 이의 제조 방법
CN108570053A (zh) * 2017-03-13 2018-09-25 中国科学院上海药物研究所 五元并六元杂环化合物、制备方法、中间体、组合和应用
KR102708681B1 (ko) 2018-02-13 2024-09-26 길리애드 사이언시즈, 인코포레이티드 Pd-1/pd-l1 억제제
EP3781556B1 (en) 2018-04-19 2025-06-18 Gilead Sciences, Inc. Pd-1/pd-l1 inhibitors
PL3820572T3 (pl) 2018-07-13 2024-02-26 Gilead Sciences, Inc. Inhibitory pd-1/pd-l1
CA3117199C (en) 2018-10-24 2024-03-19 Gilead Sciences, Inc. Pd-1/pd-l1 inhibitors
AU2023206890A1 (en) 2022-01-12 2024-08-22 Denali Therapeutics Inc. Crystalline forms of (s)-5-benzyl-n-(5-methyl-4-oxo-2, 3,4,5- tetrahydropyrido [3,2-b] [l,4]oxazepin-3-yl)-4h-l,2,4-triazole-3-carboxamide

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9624482D0 (en) 1995-12-18 1997-01-15 Zeneca Phaema S A Chemical compounds
DE19604388A1 (de) 1996-02-07 1997-08-14 Merck Patent Gmbh Arylalkyl-diazinone
JP4471404B2 (ja) 1996-02-13 2010-06-02 アストラゼネカ ユーケイ リミテッド Vegfインヒビターとしてのキナゾリン誘導体
KR100489174B1 (ko) 1996-03-05 2005-09-30 제네카-파마 소시에떼아노님 4-아닐리노퀴나졸린유도체
GB9718972D0 (en) 1996-09-25 1997-11-12 Zeneca Ltd Chemical compounds
JPH10259176A (ja) 1997-03-17 1998-09-29 Japan Tobacco Inc 血管新生阻害作用を有する新規アミド誘導体及びその用途
GB9714249D0 (en) 1997-07-08 1997-09-10 Angiogene Pharm Ltd Vascular damaging agents
TWI241295B (en) 1998-03-02 2005-10-11 Kowa Co Pyridazine derivative and medicine containing the same as effect component
GB9900334D0 (en) 1999-01-07 1999-02-24 Angiogene Pharm Ltd Tricylic vascular damaging agents
GB9900752D0 (en) 1999-01-15 1999-03-03 Angiogene Pharm Ltd Benzimidazole vascular damaging agents
AUPQ462299A0 (en) 1999-12-13 2000-01-13 Fujisawa Pharmaceutical Co., Ltd. Pyrazolopyridine compound and pharmaceutical use thereof
US6242461B1 (en) * 2000-01-25 2001-06-05 Pfizer Inc. Use of aryl substituted azabenzimidazoles in the treatment of HIV and AIDS related diseases
BR0111230A (pt) 2000-05-31 2003-06-10 Astrazeneca Ab Composto, e, uso e processo para a preparação do mesmo
BR0112224A (pt) 2000-07-07 2003-06-10 Angiogene Pharm Ltd Composto, composição farmacêutica, uso de um composto ou de um sal, solvato ou pró-droga farmaceuticamente aceitável do mesmo, e, processo para preparar um composto
SK52003A3 (en) 2000-07-07 2003-07-01 Angiogene Pharm Ltd Colchinol derivatives as angiogenesis inhibitors, method for their preparation and pharmaceutical composition comprising the same
HUP0401984A3 (en) * 2001-10-31 2005-06-28 Merck Patent Gmbh Use of type 4 phosphodiesterase inhibitors for preparation of pharmaceutical compositions and combination with other active ingredients
DE10228103A1 (de) 2002-06-24 2004-01-15 Bayer Cropscience Ag Fungizide Wirkstoffkombinationen
EP1572693A1 (en) * 2002-12-20 2005-09-14 Pharmacia Corporation Mitogen activated protein kinase-activated protein kinase-2 inhibiting compounds
US7563748B2 (en) 2003-06-23 2009-07-21 Cognis Ip Management Gmbh Alcohol alkoxylate carriers for pesticide active ingredients
MXPA06000091A (es) 2003-07-02 2006-04-07 Sugen Inc Arilmetiltriazolo e imidazopirazinas como inhibidores de c-met.
US7959919B2 (en) * 2003-11-19 2011-06-14 Novelmed Therapeutics, Inc. Method of inhibiting factor B-mediated complement activation
EP1769092A4 (en) 2004-06-29 2008-08-06 Europ Nickel Plc IMPROVED LIXIVIATION OF BASE METALS
WO2006015263A2 (en) * 2004-07-29 2006-02-09 Threshold Pharmaceuticals, Inc. Lonidamine analogs
US20070015771A1 (en) * 2004-07-29 2007-01-18 Threshold Pharmaceuticals, Inc. Lonidamine analogs
US20070043057A1 (en) * 2005-02-09 2007-02-22 Threshold Pharmaceuticals, Inc. Lonidamine analogs
DE602006020138D1 (de) 2005-06-29 2011-03-31 Compumedics Ltd Sensoranordnung mit leitfähiger brücke
KR20080080584A (ko) 2005-11-30 2008-09-04 버텍스 파마슈티칼스 인코포레이티드 c-Met의 억제제 및 이의 용도
DE102005057924A1 (de) * 2005-12-05 2007-06-06 Merck Patent Gmbh Pyridazinonderivate
MY159523A (en) * 2005-12-21 2017-01-13 Janssen Pharmaceutica Nv Triazolopyridazines as tyrosine kinase modulators
NL2000613C2 (nl) 2006-05-11 2007-11-20 Pfizer Prod Inc Triazoolpyrazinederivaten.
CA2651979A1 (en) 2006-05-30 2007-12-06 Pfizer Products Inc. Triazolopyridazine derivatives
TW200801513A (en) 2006-06-29 2008-01-01 Fermiscan Australia Pty Ltd Improved process
PE20121506A1 (es) * 2006-07-14 2012-11-26 Amgen Inc Compuestos triazolopiridinas como inhibidores de c-met
WO2008033455A2 (en) * 2006-09-13 2008-03-20 The Institutes For Pharmaceutical Discovery, Llc Biphenyl and heteroaryl phenyl derivatives as protein tyrosine phosphatases inhibitors
MX2009004060A (es) 2006-10-23 2009-06-19 Sgx Pharmaceuticals Inc Moduladores de proteina cinasa de triazolpiridazina.
DE102007026341A1 (de) * 2007-06-06 2008-12-11 Merck Patent Gmbh Benzoxazolonderivate
DE102007032507A1 (de) * 2007-07-12 2009-04-02 Merck Patent Gmbh Pyridazinonderivate
KR20100084516A (ko) * 2007-10-31 2010-07-26 닛산 가가쿠 고교 가부시키 가이샤 피리다지논 유도체 및 이의 p2x7 수용체 억제제로서의 용도
DE102007061963A1 (de) * 2007-12-21 2009-06-25 Merck Patent Gmbh Pyridazinonderivate
CN101537006B (zh) * 2008-03-18 2012-06-06 中国科学院上海药物研究所 哒嗪酮类化合物在制备抗肿瘤药物中的用途
DE102008019907A1 (de) * 2008-04-21 2009-10-22 Merck Patent Gmbh Pyridazinonderivate
WO2009142732A2 (en) * 2008-05-20 2009-11-26 Cephalon, Inc. Substituted pyridazinone derivatives as histamine-3 (h3) receptor ligands
DE102008028905A1 (de) * 2008-06-18 2009-12-24 Merck Patent Gmbh 3-(3-Pyrimidin-2-yl-benzyl)-[1,2,4]triazolo[4,3-b]pyridazinderivate
WO2010010150A1 (en) * 2008-07-25 2010-01-28 Boehringer Ingelheim International Gmbh Synthesis of inhibitors of 11beta-hydroxysteroid dehydrogenase type 1
WO2010113986A1 (ja) * 2009-03-30 2010-10-07 住友化学株式会社 ピリダジノン化合物の有害節足動物防除用途
AR082590A1 (es) * 2010-08-12 2012-12-19 Hoffmann La Roche Inhibidores de la tirosina-quinasa de bruton

Similar Documents

Publication Publication Date Title
JP2011530545A5 (cg-RX-API-DMAC10.html)
JP2010532768A5 (cg-RX-API-DMAC10.html)
JP2010529051A5 (cg-RX-API-DMAC10.html)
JP2012532901A5 (cg-RX-API-DMAC10.html)
JP2010528995A5 (cg-RX-API-DMAC10.html)
JP2011518202A5 (cg-RX-API-DMAC10.html)
JP2012532899A5 (cg-RX-API-DMAC10.html)
CN113784970A (zh) Erk抑制剂及其应用
RU2013108865A (ru) Производные хинолина и содержащие их ингибиторы melk
JP2017141277A5 (cg-RX-API-DMAC10.html)
CN114072396A (zh) 作为dna-pk抑制剂的喹啉和噌啉衍生物
JP2018516963A5 (cg-RX-API-DMAC10.html)
RU2013131004A (ru) Комбинация (а) ингибитора фосфоинозит-3-киназы и (б) модулятора пути ras/raf/mek
JP2018115201A5 (cg-RX-API-DMAC10.html)
JP2010053135A5 (cg-RX-API-DMAC10.html)
JP2015529229A5 (cg-RX-API-DMAC10.html)
RU2013121788A (ru) Ингибиторы репликации вич
RU2015118647A (ru) Аминопиримидиновые соединения в качестве ингибиторов содержащих т790м мутантных egfr
JP2015524450A5 (cg-RX-API-DMAC10.html)
JP2013509429A5 (cg-RX-API-DMAC10.html)
JP2013510120A5 (cg-RX-API-DMAC10.html)
JP2011504903A5 (cg-RX-API-DMAC10.html)
IL273177B2 (en) Fluorophenyl beta-hydroxyethylamines and their uses in the treatment of hyperglycemia
EA201391337A1 (ru) Ингибиторы hsp90
JP2016531871A5 (cg-RX-API-DMAC10.html)